| 1. |
- Gawel, Danuta, et al.
(författare)
-
A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases
- 2019
-
Ingår i: Genome Medicine. - : Springer Science and Business Media LLC. - 1756-994X. ; 11
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Genomic medicine has paved the way for identifying biomarkers and therapeutically actionable targets for complex diseases, but is complicated by the involvement of thousands of variably expressed genes across multiple cell types. Single-cell RNA-sequencing study (scRNA-seq) allows the characterization of such complex changes in whole organs. Methods: The study is based on applying network tools to organize and analyze scRNA-seq data from a mouse model of arthritis and human rheumatoid arthritis, in order to find diagnostic biomarkers and therapeutic targets. Diagnostic validation studies were performed using expression profiling data and potential protein biomarkers from prospective clinical studies of 13 diseases. A candidate drug was examined by a treatment study of a mouse model of arthritis, using phenotypic, immunohistochemical, and cellular analyses as read-outs. Results: We performed the first systematic analysis of pathways, potential biomarkers, and drug targets in scRNA-seq data from a complex disease, starting with inflamed joints and lymph nodes from a mouse model of arthritis. We found the involvement of hundreds of pathways, biomarkers, and drug targets that differed greatly between cell types. Analyses of scRNA-seq and GWAS data from human rheumatoid arthritis (RA) supported a similar dispersion of pathogenic mechanisms in different cell types. Thus, systems-level approaches to prioritize biomarkers and drugs are needed. Here, we present a prioritization strategy that is based on constructing network models of disease-associated cell types and interactions using scRNA-seq data from our mouse model of arthritis, as well as human RA, which we term multicellular disease models (MCDMs). We find that the network centrality of MCDM cell types correlates with the enrichment of genes harboring genetic variants associated with RA and thus could potentially be used to prioritize cell types and genes for diagnostics and therapeutics. We validated this hypothesis in a large-scale study of patients with 13 different autoimmune, allergic, infectious, malignant, endocrine, metabolic, and cardiovascular diseases, as well as a therapeutic study of the mouse arthritis model. Conclusions: Overall, our results support that our strategy has the potential to help prioritize diagnostic and therapeutic targets in human disease.
|
|
| 2. |
|
|
| 3. |
- Alexeyenko, Andrey, et al.
(författare)
-
Comparative interactomics with Funcoup 2.0
- 2012
-
Ingår i: Nucleic Acids Research. - : Oxford University Press (OUP). - 0305-1048 .- 1362-4962. ; 40:D1, s. D821-D828
-
Tidskriftsartikel (refereegranskat)abstract
- FunCoup (http://FunCoup.sbc.su.se) is a database that maintains and visualizes global gene/protein networks of functional coupling that have been constructed by Bayesian integration of diverse high-throughput data. FunCoup achieves high coverage by orthology-based integration of data sources from different model organisms and from different platforms. We here present release 2.0 in which the data sources have been updated and the methodology has been refined. It contains a new data type Genetic Interaction, and three new species: chicken, dog and zebra fish. As FunCoup extensively transfers functional coupling information between species, the new input datasets have considerably improved both coverage and quality of the networks. The number of high-confidence network links has increased dramatically. For instance, the human network has more than eight times as many links above confidence 0.5 as the previous release. FunCoup provides facilities for analysing the conservation of subnetworks in multiple species. We here explain how to do comparative interactomics on the FunCoup website.
|
|
| 4. |
- Dwivedi, Sanjiv, et al.
(författare)
-
Deriving disease modules from the compressed transcriptional space embedded in a deep autoencoder
- 2020
-
Ingår i: Nature Communications. - : NATURE PUBLISHING GROUP. - 2041-1723. ; 11:1
-
Tidskriftsartikel (refereegranskat)abstract
- Disease modules in molecular interaction maps have been useful for characterizing diseases. Yet biological networks, that commonly define such modules are incomplete and biased toward some well-studied disease genes. Here we ask whether disease-relevant modules of genes can be discovered without prior knowledge of a biological network, instead training a deep autoencoder from large transcriptional data. We hypothesize that modules could be discovered within the autoencoder representations. We find a statistically significant enrichment of genome-wide association studies (GWAS) relevant genes in the last layer, and to a successively lesser degree in the middle and first layers respectively. In contrast, we find an opposite gradient where a modular protein-protein interaction signal is strongest in the first layer, but then vanishing smoothly deeper in the network. We conclude that a data-driven discovery approach is sufficient to discover groups of disease-related genes. The study of disease modules facilitates insight into complex diseases, but their identification relies on knowledge of molecular networks. Here, the authors show that disease modules and genes can also be discovered in deep autoencoder representations of large human gene expression datasets.
|
|
| 5. |
- Magnusson, Rasmus, 1992-
(författare)
-
High Confidence Network Predictions from Big Biological Data
- 2020
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- Biology functions in a most intriguing fashion, with human cells being regulated by multiplex networks of proteins and their dependent systems that control everything from proliferation to cell death. Notably, there are cases when these networks fail to function properly. In some diseases there are multiple small perturbations that push the otherwise healthy cells into a state of malfunction. These maladies are referred to as complex diseases, and include common disorders such as allergy, diabetes type II, and multiple sclerosis, and due to their complexity there is no universally defined approach to fully understand their pathogenesis or pathophysiology. While these perturbations can be measured using high-throughput technologies, the interplay of these perturbations is generally to complex to understand without any structured mathematical analysis. There is today numerous such methods that put the small perturbations of complex diseases into relation of interactions among each other. However, the methods have historically struggled with notable uncertainty in their predictions.This uncertainty can be addressed by at least two different approaches. First, mechanistically realistic mathematical modelling is an approach that has the capacity to accurately describe almost any biological system, but such models can to-date only describe small systems and networks. Secondly, large-scale mathematical modelling approaches exist, but the faithfulness of the models to the underlying biology has been compromised to achieve algorithms that are computationally effective.In this Ph.D. thesis, I suggest how high confidence predictions of network interactions can be extracted from big biological. First, I show how large-scale data can be used when building high-quality ODE models (Paper I). Secondly, by developing the software LASSIM, I show how ODE models can be expanded to the size of entire cell systems (Paper II). However, while LASSIM showed that powerful non-linear ODE-modelling can be applied to understand big biological data, it still remained a machine learning-based approach in contrast to hypothesis-driven model development.Instead, two more studies revolving around large-scale modelling approaches were initiated. The third study suggested that ambiguities in model selection and interaction identification greatly compromise the accuracy of available tools, and that the novel software of Paper III, LiPLike, can be used to remove such predictions. Intriguingly, while LiPLike was able to effectively discard false identifications, the accuracy of predictions remained relatively low. This low accuracy was thought to arise from model simplifications, and therefore the next study aimed at finding methods that come closer to the true biological system (Paper IV). In particular, the study aimed at predicting protein abundance -the true mediators of biological functionality- from the much more easily accessible mRNA levels, and found that such models could be used to get several new insights on protein mechanisms, which was exemplified by the identification of important biomarkers of autoimmune diseases.The analysis of big biological data and the underlying networks is a centrepiece of understanding both diseases and how cell functionality is orchestrated. The work that is presented in this Ph.D. thesis represents a journey between fields with different views on how these networks should be inferred. In particular, it aimed to combine the accuracy of small-scale mechanistic modelling with the system-spanning potential of large-scale linear system modelling, and this thesis thus provides a tool-bench of methods and insights on how knowledge can be extracted from big biological data, and in extension it is a small step towards a generation of new comprehensions of biological systems and complex diseases.
|
|
| 6. |
- Magnusson, Rasmus, 1992-, et al.
(författare)
-
LASSIM-A network inference toolbox for genome-wide mechanistic modeling
- 2017
-
Ingår i: PLoS Computational Biology. - : Public Library of Science (PLoS). - 1553-734X .- 1553-7358. ; 13:6, s. Article no. e1005608 -
-
Tidskriftsartikel (refereegranskat)abstract
- Recent technological advancements have made time-resolved, quantitative, multi-omics data available for many model systems, which could be integrated for systems pharmacokinetic use. Here, we present large-scale simulation modeling (LASSIM), which is a novel mathematical tool for performing large-scale inference using mechanistically defined ordinary differential equations (ODE) for gene regulatory networks (GRNs). LASSIM integrates structural knowledge about regulatory interactions and non-linear equations with multiple steady state and dynamic response expression datasets. The rationale behind LASSIM is that biological GRNs can be simplified using a limited subset of core genes that are assumed to regulate all other gene transcription events in the network. The LASSIM method is implemented as a general-purpose toolbox using the PyGMO Python package to make the most of multicore computers and high performance clusters, and is available at https://gitlab.com/Gustafsson-lab/lassim. As a method, LASSIM works in two steps, where it first infers a non-linear ODE system of the pre-specified core gene expression. Second, LASSIM in parallel optimizes the parameters that model the regulation of peripheral genes by core system genes. We showed the usefulness of this method by applying LASSIM to infer a large-scale non-linear model of naive Th2 cell differentiation, made possible by integrating Th2 specific bindings, time-series together with six public and six novel siRNA-mediated knock-down experiments. ChIP-seq showed significant overlap for all tested transcription factors. Next, we performed novel time-series measurements of total T-cells during differentiation towards Th2 and verified that our LASSIM model could monitor those data significantly better than comparable models that used the same Th2 bindings. In summary, the LASSIM toolbox opens the door to a new type of model-based data analysis that combines the strengths of reliable mechanistic models with truly systems-level data. We demonstrate the power of this approach by inferring a mechanistically motivated, genome-wide model of the Th2 transcription regulatory system, which plays an important role in several immune related diseases.
|
|
| 7. |
- Morgan, Daniel, 1988-, et al.
(författare)
-
A generalized framework for controlling FDR in gene regulatory network inference
- 2019
-
Ingår i: Bioinformatics. - : Oxford University Press (OUP). - 1367-4803 .- 1367-4811. ; 35:6, s. 1026-1032
-
Tidskriftsartikel (refereegranskat)abstract
- Motivation: Inference of gene regulatory networks (GRNs) from perturbation data can give detailed mechanistic insights of a biological system. Many inference methods exist, but the resulting GRN is generally sensitive to the choice of method-specific parameters. Even though the inferred GRN is optimal given the parameters, many links may be wrong or missing if the data is not informative. To make GRN inference reliable, a method is needed to estimate the support of each predicted link as the method parameters are varied.Results: To achieve this we have developed a method called nested bootstrapping, which applies a bootstrapping protocol to GRN inference, and by repeated bootstrap runs assesses the stability of the estimated support values. To translate bootstrap support values to false discovery rates we run the same pipeline with shuffled data as input. This provides a general method to control the false discovery rate of GRN inference that can be applied to any setting of inference parameters, noise level, or data properties. We evaluated nested bootstrapping on a simulated dataset spanning a range of such properties, using the LASSO, Least Squares, RNI, GENIE3 and CLR inference methods. An improved inference accuracy was observed in almost all situations. Nested bootstrapping was incorporated into the GeneSPIDER package, which was also used for generating the simulated networks and data, as well as running and analyzing the inferences.
|
|
| 8. |
- Morgan, Daniel, et al.
(författare)
-
Perturbation-based gene regulatory network inference to unravel oncogenic mechanisms
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- Motivation: Cancer is known to stem from multiple, independent mutations, the effects of which aggregate to drive the cell into a cancerous state. To understand the complex interplay between affected genes, their gene regulatory network (GRN) needs to be uncovered, to revealing detailed insights of regulatory mechanisms. We therefore decided to infer a reliable GRN from perturbation responses of 40 genes known or suspected to have a role in human cancers yet whose regulatory interactions are poorly known.Results: siRNA knockdown experiments of each gene were done in a human squamous carcinoma cell line, after which the transcriptomic response was measured. From these data GRNs were inferred using several methods, and the false discovery rate was controlled by the NestBoot framework. The best GRN was shown to be significantly more predictive than the null model, both in crossvalidated benchmarks and for an independent dataset of the same genes but subjected to double perturbations. It agrees with many known links in addition to predicting a large number of novel interactions, a subset of which were experimentally validated. The inferred GRN captures regulatory interactions central to cancer-relevant processes and thus provides mechanistic insights that are useful for future cancer research.
|
|
| 9. |
- Morgan, Daniel, et al.
(författare)
-
Perturbation-based gene regulatory network inference to unravel oncogenic mechanisms
- 2020
-
Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 10:1
-
Tidskriftsartikel (refereegranskat)abstract
- The gene regulatory network (GRN) of human cells encodes mechanisms to ensure proper functioning. However, if this GRN is dysregulated, the cell may enter into a disease state such as cancer. Understanding the GRN as a system can therefore help identify novel mechanisms underlying disease, which can lead to new therapies. To deduce regulatory interactions relevant to cancer, we applied a recent computational inference framework to data from perturbation experiments in squamous carcinoma cell line A431. GRNs were inferred using several methods, and the false discovery rate was controlled by the NestBoot framework. We developed a novel approach to assess the predictiveness of inferred GRNs against validation data, despite the lack of a gold standard. The best GRN was significantly more predictive than the null model, both in cross-validated benchmarks and for an independent dataset of the same genes under a different perturbation design. The inferred GRN captures many known regulatory interactions central to cancer-relevant processes in addition to predicting many novel interactions, some of which were experimentally validated, thus providing mechanistic insights that are useful for future cancer research.
|
|
| 10. |
- Secilmis, Deniz, et al.
(författare)
-
A Subset Selection Method for Accurate Gene Regulatory Network Inference of Uninformative Datasets
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- Motivation: The interactions among the components of a living cell that constitute the gene regulatory network (GRN) can be inferred from perturbation-based gene expression data. Such networks are useful for providing mechanistic insights of a biological system. In order to explore the feasibility and quality of GRN inference at a large scale, we used the L1000 data where approximately 1000 genes have been perturbed and their expression levels have been quantified in 9 cancer cell lines. First we identified key properties of the datasets, i.e., signal-to-noise ratio (SNR) and condition number which we have shown to affect the performance of various inference methods.Results: We found that all L1000 datasets have a very low SNR level causing them to be highly uninformative not suitable to infer accurate GRNs. Therefore, we have developed a gene reduction pipeline in which we eliminate the uninformative genes from the system using a selection criteria based on SNR until reaching an informative subset. The results show that our pipeline can identify an informative subset in an uninformative dataset, improving the accuracy of the GRN inference significantly.
|
|
